ctrl K

Watchlist Price Alert

Contineum Therapeutics In... (CTNM)

NASDAQ: CTNM · Real-Time Price · USD

4.11

-0.18 (-4.20%)

At close: Jun 17, 2025, 1:50 PM

Contineum Therapeutics Class A Common Stock Income Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	n/a	50M	n/a	n/a
Cost of Revenue	n/a	n/a	329K	n/a
Gross Profit	n/a	50M	-329K	n/a
Operating Income	-50.89M	-16.08M	-22.72M	-28.65M
Interest Income	8.9M	4.61M	761K	77K
Pretax Income	-42.26M	23.17M	-24.25M	-29M
Net Income	-42.26M	22.72M	-24.25M	-29M
Selling & General & Admin	12.47M	6.32M	5.5M	6.29M
Research & Development	38.42M	27.6M	16.89M	22.36M
Other Expenses	n/a	32.15M	-92K	-91K
Operating Expenses	50.89M	66.08M	22.39M	28.65M
Interest Expense	n/a	208K	388K	332K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a
Cost & Expenses	50.89M	66.08M	22.72M	28.65M
Income Tax Expense	n/a	450K	n/a	241K
Shares Outstanding (Basic)	19.35M	16.67M	25.13M	16.67M
Shares Outstanding (Diluted)	19.35M	17.76M	25.13M	17.76M
EPS (Basic)	-2.18	1.36	-0.97	-1.74
EPS (Diluted)	-2.18	1.28	-0.97	-1.63
EBITDA	-42M	23.57M	-23.54M	-28.34M
EBIT	-42.26M	23.38M	-23.86M	-28.67M
Depreciation & Amortization	258K	195K	329K	325K